Deborah joined Milford in early 2020 as an Investment Analyst covering Global Equities. Prior to joining Milford, Deborah was an Associate in the Investment Banking Team at Jarden where she worked on a number of Mergers and Acquisitions & Equity Capital Markets (ECM) transactions including the sale of Aegis, the sale of TRG Imaging, the purchase of Hellers, and a number of capital raises.
Prior to this, Deborah worked as a medical Doctor at Capital & Coast District Health Board, and was Chair of the New Zealand Medical Association Doctors in Training Council. Deborah also has an interest in online education and co-founded LearnCoach with David Cameron in 2015, which is widely used by NCEA students.
Deborah holds a Bachelor of Medicine and Bachelor of Surgery, Bachelor of Medical Science (Honours), Master of Entrepreneurship (Distinction) and is a CFA Charterholder.
You may have heard of the weight loss drugs Ozempic or Wegovy. Investment Analyst Dr Deborah Lambie was on AM show on Three to discuss the rise of this new class of medicines called GLP-1’s and the potential impact they might have across the health system.
A disclosure statement is available on request and free of charge. For more information about getting advice at Milford please see Getting Advice at Milford
Disclaimer: Milford is an active manager with views and portfolio positions subject to change. This blog is intended to provide general information only. It does not take into account your investment needs or personal circumstances. It is not intended to be viewed as investment or financial advice. Should you require financial advice you should always speak to a Financial Adviser. Past performance is not a guarantee of future performance.
Previous
Monday Market Highlights: 01 April 2024
Next
From your 20s to your 60s – top tips to help create financial security
